Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001144204-17-008897

← back to feed
Filed
Feb 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Feb 14, 2017 20M sh
Stockholders Equity Q3 2017 · Dec 31, 2016 $2.36M
Stockholders Equity Q3 2017 · Mar 31, 2016 $2.18M
Current Liabilities Q3 2017 · Dec 31, 2016 $3.36M
Current Liabilities Q3 2017 · Mar 31, 2016 $3.43M
Current Assets Q3 2017 · Dec 31, 2016 $2.7M
Current Assets Q3 2017 · Mar 31, 2016 $2.86M
Total Assets Q3 2017 · Dec 31, 2016 $5.79M
Total Assets Q3 2017 · Mar 31, 2016 $5.7M
Shares Diluted Q3 2017 · Dec 31, 2015 20M sh
Shares Diluted Q3 2017 · Dec 31, 2015 20M sh
Cash And Equivalents Q3 2017 · Dec 31, 2015 $166.95K
Cash And Equivalents Q3 2017 · Mar 31, 2015 $399.15K
Eps Diluted Q3 2017 · Dec 31, 2015 $0.00
Eps Diluted Q3 2017 · Dec 31, 2015 $0.01
Eps Basic Q3 2017 · Dec 31, 2015 $0.00
Eps Basic Q3 2017 · Dec 31, 2015 $0.01
Sga Expense Q3 2017 · Dec 31, 2015 $288.02K
Sga Expense Q3 2017 · Dec 31, 2015 $819.85K
Rd Expense Q3 2017 · Dec 31, 2015 $3.52K
Rd Expense Q3 2017 · Dec 31, 2015 $8.75K
Operating Income Q3 2017 · Dec 31, 2015 −$24.15K
Operating Income Q3 2017 · Dec 31, 2015 $230.51K
Gross Profit Q3 2017 · Dec 31, 2015 $467.79K
Gross Profit Q3 2017 · Dec 31, 2015 $1.52M